Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

10645	Companies
226417	Keywords
154884	Articles
119843	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

PRESS RELEASE

published on 10/29/2024 at 11:46, 1 year 7 months ago

Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor
US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome

Clinical Trial PentixaFor Adrenal Tumors PET Scans NIH
BRIEF

published on 10/28/2024 at 12:31, 1 year 7 months ago

Nuclear Medicine Expert Ken Herrmann Joins Pentixapharm's Board

Supervisory Board Nuclear Medicine Radiopharmaceuticals Oncology Pipeline Ken Herrmann
BRIEF

published on 10/28/2024 at 12:31, 1 year 7 months ago

Ken Herrmann, expert en médecine nucléaire, rejoint le conseil d'administration de Pentixapharm

Conseil De Surveillance Produits Radiopharmaceutiques Médecine Nucléaire Ken Herrmann Pipeline En Oncologie
PRESS RELEASE

published on 10/28/2024 at 12:26, 1 year 7 months ago

Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG
Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline

Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann
BRIEF

published on 10/25/2024 at 16:05, 1 year 8 months ago

Pentixapharm Holding AG Announces Leadership Changes

Leadership Changes Supervisory Board Pentixapharm Dr. Hakim Bouterfa Dr. Dirk Pleimes
BRIEF

published on 10/25/2024 at 16:05, 1 year 8 months ago

Pentixapharm Holding AG annonce des changements au sein de sa direction

Conseil De Surveillance Changements De Direction Pentixapharm Docteur Hakim Bouterfa Dr Dirk Pleimes
PRESS RELEASE

published on 10/25/2024 at 16:00, 1 year 8 months ago

Pentixapharm Holding AG: Upcoming Changes in the Management and Supervisory Boards of the Pentixapharm Group
Pentixapharm Holding AG announces upcoming changes in management and supervisory boards, including CEO transition and new board appointments

CEO Transition Supervisory Board Management Changes Pentixapharm Holding AG Nuclear Medicine Specialist
BRIEF

published on 10/19/2024 at 12:33, 1 year 8 months ago

Pentixapharm's CXCR4 Compound Showcased at EANM Conference

Radiopharmaceuticals Pentixapharm CXCR4 Targeting EANM Conference Theranostic Development
BRIEF

published on 10/19/2024 at 12:33, 1 year 8 months ago

Le composé CXCR4 de Pentixapharm présenté à la conférence EANM

Produits Radiopharmaceutiques Pentixapharm Ciblage CXCR4 Conférence EANM Développement Théranostique
PRESS RELEASE

published on 10/19/2024 at 12:28, 1 year 8 months ago

Pentixapharm’s CXCR4 Core Compound Subject of 17 Abstract Presentations at the Hamburg European Association of Nuclear Medicine (EANM)
Pentixapharm presents CXCR4 targeting compounds in 17 abstracts at EANM Congress, showcasing theranostic developments and research initiatives in various medical areas

Radiopharmaceuticals Pentixapharm Theranostic Development CXCR4 EANM Congress

Accesswire

Published on 06/26/2026 at 12:45, 13 minutes ago

Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 01:40, 11 hours 18 minutes ago

UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 13 hours 28 minutes ago

Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 14 hours 28 minutes ago

Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 15 hours 26 minutes ago

BlackBerry Announces Election Results for the Company's Board of Directors

View all ACCESSWIRE

EQS Group

Published on 06/26/2026 at 12:30, 28 minutes ago

Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 06/26/2026 at 12:18, 40 minutes ago

EQS-Adhoc: EPH Group AG: EPH Group AG Extends Subscription Period for New EPH Shares Until 31 July 2026
Published on 06/26/2026 at 11:30, 1 hour 28 minutes ago

Amundi Index Solutions: NOTICE TO SHAREHOLDERS
Published on 06/26/2026 at 11:14, 1 hour 43 minutes ago

EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Published on 06/26/2026 at 11:05, 1 hour 53 minutes ago

Join the Beautiful Game: Discover Immersive Fan Experiences with Hisense at FIFA World Cup 2026™

Les Echos

Published on 06/26/2026 at 12:16, 42 minutes ago

Rapport semestriel SIEHM au 30 avril 2026
Published on 06/26/2026 at 07:00, 5 hours 58 minutes ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 5 hours 58 minutes ago

Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 18 hours 13 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 18 hours 28 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026

View all LES ECHOS COMFI WIRE